Corcept Therapeutics Incorporated earnings per share and revenue

CORT earnings per share for the last quarter are 0.29 USD whereas the estimation was 0.19 USD which accounts for 54.67% surprise. Company revenue for the same period amounts to 194.43 M USD despite the estimated figure of 199.39 M USD. Estimated earnings per share for the next quarter are 0.17 USD, and revenue is expected to reach 223.78 M USD. Also watch annual changes over time to get a bigger picture of CORT earnings per share and revenue dynamics.